These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 8374873)

  • 1. Re-induction chemotherapy using FLAG-mitoxantrone for adult patients with relapsed acute leukemia: a single-center experience from United Arab Emirates.
    Hassan IB; Kristensen J; Al Qawasmeh K; Alam A
    Int J Hematol; 2018 Oct; 108(4):390-401. PubMed ID: 29951735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report.
    Annaloro C; Costa A; Fracchiolla NS; Mometto G; Artuso S; Saporiti G; Tagliaferri E; Grifoni F; Onida F; Cortelezzi A
    Clin Case Rep; 2015 Jul; 3(7):650-5. PubMed ID: 26273463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mortality and response rate after FLANG regimen in patients with refractory/relapsed acute leukemia.
    Mehrzad VA; Liaghat L; Ashrafi F; Tazhibi M; Hajalikhani M; Alijanian N
    Adv Biomed Res; 2012; 1():54. PubMed ID: 23326785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute lymphoblastic leukaemia : a new era.
    Apostolidou E; Swords R; Alvarado Y; Giles FJ
    Drugs; 2007; 67(15):2153-71. PubMed ID: 17927282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.
    Adkins JC; Peters DH; Markham A
    Drugs; 1997 Jun; 53(6):1005-37. PubMed ID: 9179529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine in the management of malignant lymphomas.
    Hiddemann W; Pott-Hoeck C
    Drugs; 1994; 47 Suppl 6():50-6. PubMed ID: 7525189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with fludarabine treatment and review of the literature].
    Telek B; Rejtó L; Kiss A; Batár P; Reményi G; Rák K; Udvardy M
    Orv Hetil; 2002 Jun; 143(24):1459-65. PubMed ID: 12138643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High doses of cytosine arabinoside in the treatment of patients with acute relapsing or refractory leukemia].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ; Marín-López A
    Rev Invest Clin; 1989; 41(2):139-45. PubMed ID: 2675236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia.
    Suki S; Kantarjian H; Gandhi V; Estey E; O'Brien S; Beran M; Rios MB; Plunkett W; Keating M
    Cancer; 1993 Oct; 72(7):2155-60. PubMed ID: 8374873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia.
    Vidarsson B; Abonour R; Williams EC; Woodson RD; Turman NJ; Kim K; Mosher DF; Wiersma SR; Longo WL
    Leuk Lymphoma; 2001 Apr; 41(3-4):321-31. PubMed ID: 11378544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.
    Avramis VI; Wiersma S; Krailo MD; Ramilo-Torno LV; Sharpe A; Liu-Mares W; Kowck R; Reaman GH; Sato JK
    Clin Cancer Res; 1998 Jan; 4(1):45-52. PubMed ID: 9516951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
    Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
    Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.
    Estey E; Plunkett W; Gandhi V; Rios MB; Kantarjian H; Keating MJ
    Leuk Lymphoma; 1993 Mar; 9(4-5):343-50. PubMed ID: 8394169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology.
    Gandhi V; Robertson LE; Keating MJ; Plunkett W
    Cancer Chemother Pharmacol; 1994; 34(1):30-6. PubMed ID: 8174200
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.